SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001100682-21-000025
Filing Date
2021-12-15
Accepted
2021-12-15 16:35:30
Documents
13
Period of Report
2021-12-13
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crl-20211213.htm   iXBRL 8-K 34369
2 EX-3.1 exhibit31121321.htm EX-3.1 273711
  Complete submission text file 0001100682-21-000025.txt   484080

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crl-20211213.xsd EX-101.SCH 1897
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crl-20211213_lab.xml EX-101.LAB 25133
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crl-20211213_pre.xml EX-101.PRE 13044
6 EXTRACTED XBRL INSTANCE DOCUMENT crl-20211213_htm.xml XML 11321
Mailing Address 251 BALLARDVALE ST WILMINGTON MA 01887
Business Address 251 BALLARDVALE ST WILMINGTON MA 01887 781-222-6000
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (Filer) CIK: 0001100682 (see all company filings)

IRS No.: 061397316 | Fiscal Year End: 1225
Type: 8-K | Act: 34 | File No.: 001-15943 | Film No.: 211494617
SIC: 8731 Services-Commercial Physical & Biological Research